anmelden
FTSE 100
10.412,09
PKT
-26,57
PKT
-0,25
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.02.16 | Barclays overweight | JP Morgan Chase & Co. | |
| 11.02.16 | HSBC Underweight | JP Morgan Chase & Co. | |
| 11.02.16 | GSK Neutral | UBS AG | |
| 10.02.16 | HSBC Neutral | Nomura | |
| 10.02.16 | Barclays buy | Nomura | |
| 10.02.16 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 10.02.16 | Rio Tinto buy | UBS AG | |
| 10.02.16 | Glencore Hold | Société Générale Group S.A. (SG) | |
| 09.02.16 | Barclays Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.16 | Lloyds Banking Group Neutral | Goldman Sachs Group Inc. | |
| 09.02.16 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 09.02.16 | AstraZeneca buy | UBS AG | |
| 09.02.16 | Glencore overweight | JP Morgan Chase & Co. | |
| 09.02.16 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 09.02.16 | Barclays Underperform | BNP PARIBAS | |
| 09.02.16 | HSBC Neutral | BNP PARIBAS | |
| 09.02.16 | Lloyds Banking Group Underperform | BNP PARIBAS | |
| 09.02.16 | Glencore Neutral | Goldman Sachs Group Inc. | |
| 09.02.16 | Rio Tinto Sell | Goldman Sachs Group Inc. | |
| 08.02.16 | AstraZeneca Halten | Independent Research GmbH | |
| 08.02.16 | AstraZeneca Hold | HSBC | |
| 05.02.16 | Vodafone Group buy | Deutsche Bank AG | |
| 05.02.16 | AstraZeneca buy | Deutsche Bank AG | |
| 05.02.16 | Rio Tinto buy | Société Générale Group S.A. (SG) | |
| 05.02.16 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 05.02.16 | Barclays market-perform | Bernstein Research | |
| 05.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 05.02.16 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 05.02.16 | Unilever overweight | JP Morgan Chase & Co. | |
| 05.02.16 | Unilever overweight | JP Morgan Chase & Co. | |
| 05.02.16 | Prudential Neutral | JP Morgan Chase & Co. | |
| 05.02.16 | Barclays buy | Jefferies & Company Inc. | |
| 05.02.16 | AstraZeneca buy | UBS AG | |
| 05.02.16 | Vodafone Group buy | UBS AG | |
| 05.02.16 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 05.02.16 | Vodafone Group buy | Nomura | |
| 05.02.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 04.02.16 | Shell (ex Royal Dutch Shell) Hold | S&P Capital IQ | |
| 04.02.16 | AstraZeneca Hold | S&P Capital IQ | |
| 04.02.16 | GSK Equal-Weight | Morgan Stanley |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.